CIDP/autoimmune nodopathies with nephropathy: a case series study.
Yuwei TangJing LiuFeng GaoHongjun HaoZhirong JiaWei ZhangXin ShiWei LiangMeng YuHe LvYing TanZhiying LiYu WangYun YuanLingchao MengZhaoxia WangPublished in: Annals of clinical and translational neurology (2023)
Anti-CNTN1 antibody was the most frequent antibody in this group of patients with CIDP/autoimmune nodopathies and nephropathy. Our study suggested that there might be some clinical and pathological differences between the antibody positive and negative patients.